Research indicates that disruption in dopamine D2 receptor function or availability may be associated with cognitive disorders like schizophrenia [49], attention deficit hyperactivity disorder [50], stress [51], and other conditions affecting cognitive function. This evidence concerns the gene DRD2 and schizophrenia.